MedPath

ECARF Institute GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Long-term Effect of a 3-month Supplementation With Holo-BLG on House Dust Mite Induced Allergic Rhinoconjunctivitis

Completed
Conditions
Allergic Rhinitis
Dust Mite Allergy
First Posted Date
2021-05-05
Last Posted Date
2022-04-22
Lead Sponsor
Ecarf Institute GmbH
Target Recruit Count
27
Registration Number
NCT04872868
Locations
🇩🇪

ECARF Institute GmbH, Berlin, Germany

Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis

Completed
Conditions
Dust Mite Allergy
Allergic Rhinitis
First Posted Date
2020-07-20
Last Posted Date
2021-04-26
Lead Sponsor
Ecarf Institute GmbH
Target Recruit Count
38
Registration Number
NCT04477382
Locations
🇩🇪

ECARF Institute GmbH, Berlin, Germany

News

No news found
© Copyright 2025. All Rights Reserved by MedPath